Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ahodgins
    Junior Member
    • Jan 2010
    • 4

    #1

    DESeq2 expression level estimate in advance contrast

    Hi all,

    I'm getting stuck on something that seems like it should be simple, hoping someone can help me find my way out.

    I've produced transcriptomes for 10 genotypes across 3 environments (mostly 2 biological reps per G+E combination, a few with more reps). I've used Tophat2 to map reads, ht-seq to generate counts, and run DESeq2 with these contrasts: design=~Batch+Genotype+Env+Genotype:Env.

    Standard analyses are working fine, but I'm getting hung up on wanting to calculate per gene variance in expression level among my genotypes in each environment. I'd prefer to work with DESeq2 output over straight counts to appropriately control for technical variability in estimating expression levels, but I'm puzzled about how to extract this information from the results dataframe. Specifically, if I use a design matrix including the interaction term and then extract the contrast specifying a particular genotype and environment (results(dds_GxE, name="Genotype1.Env1")), I believe this gives me a result relative to my control genotype (Genotype0) in a matched environment (Env1). If I want the result relative to my control genotype in a single environment, but on a scale that is shared across all environments (so that I can compare population variances among the 3 environments on the same scale), I'm wondering if I need to create a dummy variable that combines genotype and environment, and then just calculate the variance on the subset of samples that happen to share one environment?

    Thanks for any insight you can offer.

    A

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...